Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep 1;5(5):1052-9.
doi: 10.1177/193229681100500505.

Glucose sensor membranes for mitigating the foreign body response

Affiliations

Glucose sensor membranes for mitigating the foreign body response

Ahyeon Koh et al. J Diabetes Sci Technol. .

Abstract

Continuous glucose monitoring devices remain limited in their duration of use due to difficulties presented by the foreign body response (FBR), which impairs sensor functionality immediately following implantation via biofouling and leukocyte infiltration. The FBR persists through the life of the implant, culminating with fibrous encapsulation and isolation from normal tissue. These issues have led researchers to develop strategies to mitigate the FBR and improve tissue integration. Studies have often focused on abating the FBR using various outer coatings, thereby changing the chemical or physical characteristics of the sensor surface. While such strategies have led to some success, they have failed to fully integrate the sensor into surrounding tissue. To further address biocompatibility, researchers have designed coatings capable of actively releasing biological agents (e.g., vascular endothelial growth factor, dexamethasone, and nitric oxide) to direct the FBR to induce tissue integration. Active release approaches have proven promising and, when combined with biocompatible coating materials, may ultimately improve the in vivo lifetime of subcutaneous glucose biosensors. This article focuses on strategies currently under development for mitigating the FBR.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hematoxylin and eosin-stained tissue surrounding glucose sensors after 28 days for devices coated with either (A) epoxy-polyurethane or (B) a hydrogel synthesized from hydroxyethyl methacrylate, 2,3-dihydroxypropyl methacrylate, N-vinyl-2-pyrrolidinone, and ethylene glycol dimethacrylate. (Reproduced with modifications with the permission of Elsevier Ltd.)
Figure 2
Figure 2
In vivo tissue response at two weeks from noncoated polyethersulfone microdialysis probes, probes coated with a hydrogel, or hydrogel-coated probes that released DX, VEGF, or both. The FBR was evaluated via histology for (A) angiogenesis and (B) inflammation. GEL, hydrogel; PES, polyethersulfone. (Reproduced with modifications with the permission of John Wiley and Sons, Inc.)
Figure 3
Figure 3
(A) Daily NO release from implanted polyarylethersulfone microdialysis probes. (B) Relative glucose recovery from subcutaneously implanted NO-releasing (red) or control (black) polyarylethersulfone probes. (Reproduced with modifications with permission of the American Chemical Society.)

References

    1. Wilson GS, Zhang Y. Introduction to the glucose sensing problem. In vivo glucose sensing. In: Cunningham DD, Stenken JA, editors. Hoboken: John Wiley & Sons; 2009.
    1. Anderson JM. Biological responses to materials. Annu Rev Mater Res. 2001;31(1):81–110.
    1. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20(2):86–100. - PMC - PubMed
    1. Thomé-Duret V, Gangnerau MN, Zhang Y, Wilson GS, Reach G. Modification of the sensitivity of glucose sensor implanted into subcutaneous tissue. Diabetes Metab. 1996;22(3):174–178. - PubMed
    1. Gerritsen M, Jansen JA, Kros A, Vriezema DM, Sommerdijk NA, Nolte RJ, Lutterman JA, Van Hövell SW, Van der Gaag A. Influence of inflammatory cells and serum on the performance of implantable glucose sensors. J Biomed Mater Res. 2001;54(1):69–75. - PubMed

Publication types

MeSH terms